Charlotte's Web Holdings, Inc.
A diversified hemp cultivation and processing company scaling its industrial acreage to capture growth in the legal recreational cannabis market.
A diversified hemp cultivation and processing company scaling its industrial acreage to capture growth in the legal recreational cannabis market.
Investors might consider this stock for its significant land bank which provides a long-term option value for scaling production as market conditions improve. The diversification of revenue streams through financial derivatives could offer a hedge against raw material price volatility, potentially stabilizing earnings in the future.
The company remains unprofitable with a substantial retained earnings deficit of over $300M and negative operating cash flow, raising concerns about its ability to sustain operations without further dilution. High debt levels relative to equity and the capital-intensive nature of hemp farming create significant pressure on liquidity in a declining revenue environment.
Charlotte's Web Holdings, Inc. is a diversified agricultural investment firm operating primarily through its subsidiary, Charlotte's Web Holding LLC, which cultivates high-value industrial hemp in the United States and Canada. The company focuses on producing premium-quality flower for legal recreational and medical cannabis markets while leveraging its extensive land bank to scale production. Its revenue streams are driven by the sale of processed hemp products, with financials reflecting operations across key agricultural regions including Colorado, Oregon, and Washington.
While revenue decreased to $49.7M in 2024 compared to prior years, net loss widened slightly to $-29.8M despite a reduction in operating expenses relative to sales volume. The cash flow from operations turned negative at $-21.3M, indicating that the company is still in an aggressive expansion phase where capital expenditures are outpacing operational cash generation.
The industrial hemp sector is characterized by rapid consolidation as smaller players exit following the 2018 Farm Bill, leaving a market dominated by a few large growers with economies of scale. Regulatory clarity continues to improve in key states, but price volatility remains high due to supply and demand imbalances in the recreational flower market.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $74.1M | $63.2M | $49.7M |
| Cost of Revenue | $54.7M | $27.6M | $28.4M |
| Gross Profit | $19.4M | $35.6M | $21.3M |
| Operating Expenses | $71.9M | $76.2M | $53.2M |
| Operating Income | $-52.5M | $-40.6M | $-32.0M |
| R&D | $3.4M | $3.0M | $2.3M |
| G&A | $70.1M | $75.6M | $53.2M |
| Stock-Based Comp | $3.4M | $2.1M | $1.5M |
| D&A | $9.0M | $15.2M | $10.0M |
| Depreciation | $6.2M | $5.1M | $4.1M |
| Amortization | $1.2M | $849.0K | $218.0K |
| Other OpEx | $-1.6M | $-2.4M | $-2.3M |
| Non-Operating Income | $-6.7M | $17.3M | $2.2M |
| Pre-Tax Income | $-59.2M | $-23.3M | $-29.8M |
| Income Tax | $91.0K | $529.0K | $39.0K |
| Continuing Ops | $-59.3M | $-23.8M | $-29.8M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-59.3M | $-23.8M | $-29.8M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-59.3M | $-23.8M | $-29.8M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $103.8M | $78.2M | $47.0M |
| Cash & Equivalents | $67.0M | $47.8M | $22.6M |
| Accounts Receivable | $1.8M | $1.9M | $1.3M |
| Inventory | $27.0M | $21.5M | $18.9M |
| Prepaid Expenses | $8.0M | $6.9M | $4.2M |
| Other Current Assets | $0 | $0 | $0 |
| Long-Term Assets | $83.9M | $74.4M | $66.5M |
| PP&E (Net) | $29.3M | $27.5M | $26.3M |
| Intangibles | $1.8M | $887.0K | $1.0M |
| Goodwill | $0 | — | — |
| Operating Leases | $16.5M | $14.6M | $12.9M |
| Other LT Assets | $36.3M | $20.4M | $15.4M |
| Total Assets | $187.6M | $152.5M | $113.4M |
| Current Liabilities | $21.4M | $23.6M | $15.9M |
| Accounts Payable | $4.0M | $2.9M | $3.4M |
| Current Leases | $2.3M | $2.3M | $2.1M |
| Other Current Liab | $8.2M | $9.9M | $5.2M |
| Long-Term Liabilities | $88.7M | $73.3M | $70.4M |
| LT Operating Leases | $17.9M | $15.7M | $13.7M |
| Other LT Liab | $70.8M | $57.7M | $56.8M |
| Total Liabilities | $110.1M | $97.0M | $86.4M |
| Shareholders' Equity | $77.5M | $55.6M | $27.1M |
| Paid-In Capital | $325.4M | $327.3M | $328.7M |
| Retained Earnings | $-247.9M | $-271.7M | $-301.6M |
| Total L&E | $187.6M | $152.5M | $113.4M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-59.3M | $-23.8M | $-29.8M |
| Non-Cash Adjustments | $50.9M | $12.9M | $6.4M |
| Working Capital Changes | $3.1M | $-4.5M | $2.2M |
| Cash from Operations | $-5.3M | $-15.4M | $-21.3M |
| Cash from Investing | $395.0K | $-3.5M | $-3.8M |
| Cash from Financing | $52.4M | $-251.0K | $-145.0K |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $47.5M | $-19.1M | $-25.2M |
| Beginning Cash | $19.5M | $67.0M | $47.8M |
| Ending Cash | $67.0M | $47.8M | $22.6M |
Primary revenue is generated from the cultivation and sale of high-CBD flower for medical and adult-use markets, supported by ancillary income from agricultural services and potential derivative financial instruments related to commodity pricing.
The company faces substantial regulatory uncertainty as state laws evolve, high volatility in agricultural commodity pricing that impacts margins, and the risk of inventory write-downs due to changing market demand or quality standards.
Significant competitive moats include a large land bank providing production scalability, proprietary genetics optimized for specific cannabinoid profiles, and established relationships with major distributors in the western US recreational market.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.